Keywords: roche, sells, otc, business, bayer, 6b, swfr
Roche sells OTC business to Bayer for 3.6B SwFr and non-RX orlistat to GSK
Article | 26 July 2004
As has been expected (Marketletters passim), Roche of Switzerland hassold its over-the-counter medicines business, including five manufacturing sites (in: Grenzach, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
